Clinical trial
A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep®…
NCT00389233 · Norgine, Industry · Completed
Key facts
| NCT number | NCT00389233 |
|---|---|
| Title | A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution |
| Official title | A Randomised, Multi-Centre, Single-Blinded, Pivotal Phase III Trial to Assess the Efficacy, Acceptability and Safety of a New 2 Litre Gut Cleansing Solution NRL994 Versus a Standard Colon Preparation With 4L PEG+E. |
| Lead sponsor | Norgine, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colonoscopy |
| Intervention type | Drug |
| Interventions | Macrogol3350 NA sulphate NACl KCl ascorbic acid NA ascorbate, Macrogol3350 Na sulphate Na bicarbonate NaCl KCl |
| Enrollment | 360 |
| Start date | Jun 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Oct 18, 2006 |
| Last update posted | Apr 16, 2008 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: